Literature DB >> 20676834

Manual versus nonmanual thrombectomy in primary and rescue percutaneous coronary angioplasty.

Giandomenico Tarsia1, Mario De Michele, Domenico Polosa, Giuseppe Biondi-Zoccai, Fabio Costantino, Giuseppe Del Prete, Rocco Aldo Osanna, Pasquale Innelli, Francesco Sisto, Imad Sheiban, Pasquale Lisanti.   

Abstract

Although many thrombectomy devices have been tested in ST-segment elevation acute myocardial infarction (STEMI), there are no comparative data on safety or effectiveness in thrombectomy or ST-segment resolution. This study compares manual versus nonmanual thrombectomy devices in patients undergoing primary or rescue percutaneous coronary intervention in a tertiary care center. We identified 232 consecutive patients with STEMI and time from symptom onset to emergency room contact of < or = 12 h undergoing percutaneous coronary intervention with coronary thrombectomy devices. Primary end point was ST-segment resolution of > or = 70%. Several angiographic, procedural and clinical secondary end points were also evaluated. The manual thrombectomy group included 110 patients and the nonmanual group 122 patients. Both groups were similar in their clinical characteristics. The primary end point occurred with similar frequency in patients treated with manual versus nonmanual thrombectomy (67.9% vs 60.0%, P = 0.216). No significant differences were found in the two groups with regard to procedural complications, angiographic reperfusion parameters, in-hospital major adverse cardiac events, or infarct size, whereas manual thrombectomy was associated with a better left ventricle ejection fraction at discharge. Furthermore, treatment with a manual thrombectomy device was associated with significantly shorter procedural times (69 min vs 95 min, P < 0.001) and lower procedural costs (2981 euros vs 7505 euros, P < 0.001). The use of manual thrombus-aspiration catheters appeared equivalent to nonmanual thrombectomy devices in the setting of primary or rescue percutaneous intervention in terms of clinical efficacy, and led to shorter procedures and cost savings.

Entities:  

Mesh:

Year:  2010        PMID: 20676834     DOI: 10.1007/s00380-009-1198-2

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  26 in total

1.  Routine thrombectomy in percutaneous coronary intervention for acute ST-segment-elevation myocardial infarction: a randomized, controlled trial.

Authors:  Anne Kaltoft; Morten Bøttcher; Søren Steen Nielsen; Hans-Henrik Tilsted Hansen; Christian Terkelsen; Michael Maeng; Jens Kristensen; Leif Thuesen; Lars Romer Krusell; Steen Dalby Kristensen; Henning Rud Andersen; Jens Flensted Lassen; Klaus Rasmussen; Michael Rehling; Torsten Toftegaard Nielsen; Hans Erik Bøtker
Journal:  Circulation       Date:  2006-06-26       Impact factor: 29.690

2.  The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

Authors: 
Journal:  N Engl J Med       Date:  1985-04-04       Impact factor: 91.245

3.  Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle Myocardial infarction Study Group.

Authors:  A W van 't Hof; A Liem; M J de Boer; F Zijlstra
Journal:  Lancet       Date:  1997-08-30       Impact factor: 79.321

4.  Adjunctive mechanical devices to prevent distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction: a meta-analysis of randomized trials.

Authors:  Giuseppe De Luca; Harry Suryapranata; Gregg W Stone; David Antoniucci; Franz-Joseph Neumann; Massimo Chiariello
Journal:  Am Heart J       Date:  2007-03       Impact factor: 4.749

5.  Thrombus aspiration with export catheter in ST elevation myocardial infarction.

Authors:  Massimo Margheri; Guido Vittori; Tania Chechi; Elena Falchetti; John Cosgrave; Gaia Spaziani; Ilaria Ricceri; Christina Giglioli; Serafina Valente; Gian Franco Gensini
Journal:  J Interv Cardiol       Date:  2007-02       Impact factor: 2.279

6.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction).

Authors:  Elliott M Antman; Daniel T Anbe; Paul Wayne Armstrong; Eric R Bates; Lee A Green; Mary Hand; Judith S Hochman; Harlan M Krumholz; Frederick G Kushner; Gervasio A Lamas; Charles J Mullany; Joseph P Ornato; David L Pearle; Michael A Sloan; Sidney C Smith; Joseph S Alpert; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Gabriel Gregoratos; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs
Journal:  Circulation       Date:  2004-08-03       Impact factor: 29.690

Review 7.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

8.  Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group.

Authors:  A W van 't Hof; A Liem; H Suryapranata; J C Hoorntje; M J de Boer; F Zijlstra
Journal:  Circulation       Date:  1998-06-16       Impact factor: 29.690

9.  Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction.

Authors:  M A DeWood; J Spores; R Notske; L T Mouser; R Burroughs; M S Golden; H T Lang
Journal:  N Engl J Med       Date:  1980-10-16       Impact factor: 91.245

10.  Feasibility and safety of thrombectomy with TVAC aspiration catheter system for patients with acute myocardial infarction.

Authors:  Jin Yokoyama; Motoi Kushibiki; Takayuki Fujiwara; Yujin Tamura; Naotaka Maeda; Takumi Higuma; Shingo Sasaki; Fuminobu Yoshimachi; Toshiro Matsunaga; Hiroyuki Hanada; Tomohiro Osanai; Ken Okumura
Journal:  Heart Vessels       Date:  2006-01       Impact factor: 1.814

View more
  5 in total

1.  Manual vs mechanical thrombectomy during PCI for STEMI: a comprehensive direct and adjusted indirect meta-analysis of randomized trials.

Authors:  Eliano Pio Navarese; Giuseppe Tarantini; Giuseppe Musumeci; Massimo Napodano; Roberta Rossini; Mariusz Kowalewski; Anna Szczesniak; Michalina Kołodziejczak; Jacek Kubica
Journal:  Am J Cardiovasc Dis       Date:  2013-08-16

2.  A free-floating left atrial thrombus develops intermittent entrapment in the mid-ventricle during diastole.

Authors:  Mikiko Fujiwara; Hiroyuki Watanabe; Yasunori Oguma; Genbu Yamaura; Kazuyuki Ishibashi; Hiroshi Yamamoto; Kiyoshi Nobori; Kenji Iino; Fumio Yamamoto; Hiroshi Ito
Journal:  Heart Vessels       Date:  2011-11-02       Impact factor: 2.037

3.  Independent no-reflow predictors in female patients with ST-elevation acute myocardial infarction treated with primary percutaneous coronary intervention.

Authors:  Yundai Chen; Changhua Wang; Xinchun Yang; Lefeng Wang; Zhijun Sun; Hongbin Liu; Lian Chen
Journal:  Heart Vessels       Date:  2011-04-28       Impact factor: 2.037

4.  Immediate and midterm follow-up results of excimer laser application in complex percutaneous coronary interventions: Report from a single center experience.

Authors:  Giandomenico Tarsia; Mario De Michele; Nicola Viceconte; Kensuke Takagi; Carmine Biscione; Giuseppe Del Prete; Domenico Polosa; Roccoaldo Osanna; Pasquale Lisanti
Journal:  Interv Med Appl Sci       Date:  2013-03-19

5.  Platelet/lymphocyte ratio was associated with impaired myocardial perfusion and both in-hospital and long-term adverse outcome in patients with ST-segment elevation acute myocardial infarction undergoing primary coronary intervention.

Authors:  Cuneyt Toprak; Mehmet M Tabakci; Zeki Simsek; Ugur Arslantas; Halil I Durmus; Lutfi Ocal; Muhittin Demirel; Burak Ozturkeri; Ender Ozal; Ramazan Kargin
Journal:  Postepy Kardiol Interwencyjnej       Date:  2015-01-12       Impact factor: 1.426

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.